endopredict (12 genes) (Myriad Genetics)
90
Structured Review
Myriad Genetics
endopredict (12 genes)
Endopredict (12 Genes), supplied by Myriad Genetics, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/12-gene+endopredict/endopredict++12+genes+/pmc11986566-81-0-4
Average 90 stars, based on 1 article reviews
Endopredict (12 Genes), supplied by Myriad Genetics, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/12-gene+endopredict/endopredict++12+genes+/pmc11986566-81-0-4
Average 90 stars, based on 1 article reviews
endopredict (12 genes) - by Bioz Stars,
2026-09
90/100 stars
Images
1) Product Images from "Evaluation and Comparison of Prognostic Multigene Tests in Early‐Stage Breast Cancer: Which Is the Most Effective? A Literature Review Exploring Clinical Utility to Enhance Therapeutic Management in Luminal Patients"
Article Title: Evaluation and Comparison of Prognostic Multigene Tests in Early‐Stage Breast Cancer: Which Is the Most Effective? A Literature Review Exploring Clinical Utility to Enhance Therapeutic Management in Luminal Patients
Journal: Molecular Carcinogenesis
doi: 10.1002/mc.23893
Figure Legend Snippet: Modules and gene assessed with Endopredict test.
Techniques Used:
Related Articles
Microarray:Article Title: Residual risk stratification of Taiwanese breast cancers following curative therapies with the extended concurrent genes signature. Article Snippet: Introduction The aim of the study was to perform digital RNA counting to validate a gene expression signature for operable breast cancers initially treated with curative intention, and the risk of recurrence, distant metastasis, and mortality was predicted.. Methods Candidate genes were initially discovered from the coherent genomic and transcriptional alternations from microarrays, and the extended concurrent genes were used to build a risk stratification model from archived formalin-fixed paraffinembedded (FFPE) tissues with the NanoString nCounter.. Results The extended concurrent genes signature was prognostic in 144 Taiwanese breast cancers (5-year relapse-free survival: 89.8 and 69.4% for lowand high-risk group, log-rank test: P = 0.004). Reverse Transcription Polymerase Chain Reaction:Article Title: Residual risk stratification of Taiwanese breast cancers following curative therapies with the extended concurrent genes signature. Article Snippet: Introduction The aim of the study was to perform digital RNA counting to validate a gene expression signature for operable breast cancers initially treated with curative intention, and the risk of recurrence, distant metastasis, and mortality was predicted.. Methods Candidate genes were initially discovered from the coherent genomic and transcriptional alternations from microarrays, and the extended concurrent genes were used to build a risk stratification model from archived formalin-fixed paraffinembedded (FFPE) tissues with the NanoString nCounter.. Results The extended concurrent genes signature was prognostic in 144 Taiwanese breast cancers (5-year relapse-free survival: 89.8 and 69.4% for lowand high-risk group, log-rank test: P = 0.004). |
